Patients with activated B-cell like diffuse large B-cell lymphoma in high and low infectious disease areas have different inflammatory gene signatures

被引:9
|
作者
Hogfeldt, Therese [1 ]
Bahnassy, Abeer A. [2 ]
Kwiecinska, Anna [5 ,6 ]
Osterborg, Anders [1 ,7 ]
Tamm, Katja Pokrovskaja [1 ]
Porwit, Anna [8 ]
Zekri, Abdel-Rahman N. [3 ]
Lundahl, Joachim [9 ]
Khaled, Hussein M. [4 ]
Mellstedt, Hakan [1 ]
Moshfegh, Ali [1 ]
机构
[1] Karolinska Inst, Dept Oncol & Pathol, Stockholm, Sweden
[2] Cairo Univ, Natl Canc Inst, Dept Pathol, Cairo, Egypt
[3] Cairo Univ, Natl Canc Inst, Dept Canc Biol, Cairo, Egypt
[4] Cairo Univ, Natl Canc Inst, Dept Med Oncol, Cairo, Egypt
[5] Karolinska Inst, Dept Pathol, S-10401 Stockholm, Sweden
[6] Karolinska Univ Hosp Solna, SE-17176 Stockholm, Sweden
[7] Karolinska Univ Hosp Solna, Dept Hematol, SE-17176 Stockholm, Sweden
[8] Univ Hlth Network, Toronto Gen Hosp, Dept Lab Hematol, Toronto, ON, Canada
[9] Karolinska Univ Hosp, Dept Clin Immunol & Transfus Med, Stockholm, Sweden
基金
瑞典研究理事会;
关键词
Diffuse large B-cell lymphoma; gene expression; inflammation; STAT; viral infections; NON-HODGKINS-LYMPHOMA; EPSTEIN-BARR-VIRUS; HEPATITIS-C VIRUS; RECEPTOR TYROSINE KINASE; LYMPHOPROLIFERATIVE DISORDERS; HEPATOCELLULAR-CARCINOMA; DEVELOPING-COUNTRIES; RISK-FACTORS; EXPRESSION; CANCER;
D O I
10.3109/10428194.2012.738365
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease with an association with inflammation and viral infections. We hypothesize that environmental factors may be involved in the pathogenesis of DLBCL. In this study, we compared gene expression profiles of lymph node tissues from patients with DLBCL from two different geographical areas with diverse environmental exposures. Specimens from Egyptian and Swedish patients with DLBCL as well as controls were studied. Gene expression analysis using microarray and quantitative polymerase chain reaction demonstrated significantly higher expression of signal transducer and activator of transcription 3 (STAT3) in Swedish as compared to Egyptian patients and control materials from both countries. This was confirmed at protein level using confocal microscopy. The receptor tyrosine kinase ROR1, a "survival factor" for malignant cells, was overexpressed and significantly related to the STAT3 expression pattern. The difference in the expression of genes involved in inflammatory responses and in the tumorigenic process of DLBCL might relate to infectious agents and/or other environmental exposures.
引用
收藏
页码:996 / 1003
页数:8
相关论文
共 50 条
  • [31] A Phase I Clinical Trial of Systemically Delivered NEMO Binding Domain Peptide in Dogs with Spontaneous Activated B-Cell like Diffuse Large B-Cell Lymphoma
    Ndikuyeze, Georges Habineza
    Gaurnier-Hausser, Anita
    Patel, Reema
    Baldwin, Albert S.
    May, Michael J.
    Flood, Patrick
    Krick, Erika
    Propert, Kathleen J.
    Mason, Nicola J.
    PLOS ONE, 2014, 9 (05):
  • [32] CNS prophylaxis for diffuse large B-cell lymphoma
    Eyre, Toby A.
    Savage, Kerry J.
    Cheah, Chan Y.
    El-Galaly, Tarec C.
    Lewis, Katharine L.
    McKay, Pamela
    Wilson, Matthew R.
    Evens, Andrew M.
    Bobillo, Sabela
    Villa, Diego
    Maurer, Matthew J.
    Cwynarski, Kate
    Ferreri, Andres
    LANCET ONCOLOGY, 2022, 23 (09) : E416 - E426
  • [33] Palliative Radiotherapy for Diffuse Large B-cell Lymphoma
    Wright, Christopher M.
    Koroulakis, Antony I.
    Baron, Jonathan A.
    Chong, Elise A.
    Tseng, Yolanda D.
    Kurtz, Goldie
    LaRiviere, Michael
    Venigalla, Sriram
    Jones, Joshua A.
    Maity, Amit
    Mohindra, Pranshu
    Plastaras, John P.
    Paydar, Ima
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (10) : 650 - 658
  • [34] The future of immunotherapy for diffuse large B-cell lymphoma
    Duell, Johannes
    Westin, Jason
    INTERNATIONAL JOURNAL OF CANCER, 2025, 156 (02) : 251 - 261
  • [35] Cost burden of diffuse large B-cell lymphoma
    Harkins, R. Andrew
    Patel, Sharvil P.
    Flowers, Christopher R.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2019, 19 (06) : 645 - 661
  • [36] The genetic basis of diffuse large B-cell lymphoma
    Pasqualucci, Laura
    CURRENT OPINION IN HEMATOLOGY, 2013, 20 (04) : 336 - 344
  • [37] Diffuse Large B-Cell Lymphoma With Oral Manifestations
    Bulut, Emel
    Bekcioglu, Burak
    Gunhan, Omer
    Sener, Ismail
    JOURNAL OF CRANIOFACIAL SURGERY, 2011, 22 (03) : 1144 - 1147
  • [38] SOCS1 gene mutations in patients with diffuse large B-cell lymphoma
    Gavrilina, O. A.
    Zvonkov, E. E.
    Biderman, B. V.
    Severina, N. A.
    Parovichnikova, E. N.
    TERAPEVTICHESKII ARKHIV, 2015, 87 (07) : 105 - 111
  • [39] Spontaneous Remission in Localized Diffuse Large B-cell Lymphoma
    Tamas, Laszlo
    Sari, Eszter
    Repassy, Gabor
    Szabo, Peter
    Bagdi, Eniko
    Krenacs, Laszlo
    Demeter, Judit
    PATHOLOGY & ONCOLOGY RESEARCH, 2011, 17 (03) : 779 - 784
  • [40] Pembrolizumab for the treatment of diffuse large B-cell lymphoma
    Sheikh, Semira
    Kuruvilla, John
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (11) : 1119 - 1126